NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
53 hedge funds and large institutions have $3.91M invested in Navidea Biopharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
53
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.13M | |
| 2 | +$15.7K | |
| 3 | +$14K | |
| 4 |
Jane Street
New York
|
+$11K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$7K |
Top Sellers
| 1 | -$81K | |
| 2 | -$11.2K | |
| 3 | -$8K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3K |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.65K |